| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.1 | 0.7 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.099 | 0.7 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |